Phase 3 trial failure
The latest news about Phase 3 trial failure: headlines, AI summaries and the full story from every source.
- Amgen Shares Drop After Novartis' Lp(a)-Lowering Drug Fails in Trial
- Class Action Lawsuit Filed Against Gossamer Bio, Inc. Over Failed Clinical Trial Results
- Gossamer Bio Announces Failed Phase 3 Trial Results, Leading to Sharp Stock Decline
- Gossamer Bio Shareholders May Pursue Class Action Over Alleged Misleading Statements
- Class Action Lawsuit Filed Against Gossamer Bio, Inc. Over Failed Clinical Trial Results